Volume 26, Number 6—June 2020
CME ACTIVITY - Synopsis
Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–20171
Aliza Cook2, Sarah Janse, Joshua R. Watson, and Guliz Erdem
Table 2
Time from hospital admission for patients who had streptococcal toxic shock syndrome with and without rash and treatments received, Nationwide Children’s Hospital, Columbus, Ohio, USA, 2010–2017
| Time from admission, d | Rash, mean (± SD) | No rash, mean (± SD) | Ratio of geometric means (95% CI) | p value |
|---|---|---|---|---|
| Start of antimicrobial drugs | 0.45 (0.49) | 1.08 (1.57) | 0.47 (0.16–1.40) | 0.17 |
| Start of clindamycin | 0.87 (0.61) | 3.37 (2.36) | 0.24 (0.10–0.59) | <0.05 |
| Start of intravenous immunoglobulin | 1.47 (0.60) | 1.48 (0.49) | 0.97 (0.58–1.60) | 0.89 |
1Preliminary results from this study were presented at the Pediatric Academic Societies Meeting, May 6–9, 2017, San Diego, California, USA; and at IDWeek 2018, October 3–7, 2018, San Francisco, California, USA.
2Current affiliation: Yale New Haven Hospital, New Haven, Connecticut, USA.
Page created: May 14, 2020
Page updated: May 14, 2020
Page reviewed: May 14, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.